Concerns on perioperative anaemia management in the FIT trial

Affiliations

¹ The Jikei University Hospital, Tokyo 1058471, Japan. Electronic address: tomosatou@jikei.ac.jp.
² The Jikei University School of Medicine, Tokyo, Japan.

Comment

Tomohiko Sato et al. Lancet Haematol. 2023 Jul.

. 2023 Jul;10(7):e485-e486.

doi: 10.1016/S2352-3026(23)00131-X.

¹ The Jikei University Hospital, Tokyo 1058471, Japan. Electronic address: tomosatou@jikei.ac.jp.
² The Jikei University School of Medicine, Tokyo, Japan.

No abstract available

Conflict of interest statement

TS and KK have received joint research funding from the Japanese Red Cross Society. KU declares no competing interests.

Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial.
Talboom K, Borstlap WAA, Roodbeen SX, Bruns ERJ, Buskens CJ, Hompes R, Tytgat KMAJ, Tuynman JB, Consten ECJ, Heuff G, Kuiper T, van Geloven AAW, Veldhuis GJ, van der Hoeven JAB, Gerhards MF, Sietses C, Spinelli A, van de Ven AWH, van der Zaag ES, Westerterp M, van Westreenen HL, Dijkgraaf ML, Juffermans NP, Bemelman WA; FIT collaborative group. Talboom K, et al. Lancet Haematol. 2023 Apr;10(4):e250-e260. doi: 10.1016/S2352-3026(22)00402-1. Epub 2023 Feb 27. Lancet Haematol. 2023. PMID: 36863386 Clinical Trial.